IMP 08P1707F0

· Unither Pharmaceuticals, France

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for IMP 08P1707F0, covering 2024-11-08 to 2024-11-08. Get the full timeline:

Most recent: Clinical Trial Update: Bioequivalence of IMP 08P1707F0 Relative to Pulmicort® (1.0 Mg/2 Ml Suspension) [Phase 1]